IRIN HIV/AIDS Weekly - 268: 27-Jan-06
IRIN HIV/AIDS Weekly - 268
Africa
27 January 2006
NEWS:
AFRICA: Uninterrupted ART vital to longevity - new study
SOUTH AFRICA: Concern as MSF starts handover of HIV/AIDS treatment
ZIMBABWE: More children abused as situation worsens
NAMIBIA: Poor access to treatment hampers fight against TB
ZAMBIA: Promising new combination therapy reduces MTCT
SWAZILAND: Campaign to inform women of their legal rights underway
EVENTS
1. Behaviour Change Communication Training Course
2. MSM at AIDS2006
JOBS
1. Global Fund recruiting experts to serve on the Technical Review Panel
(TRP)
NEWS
AFRICA: Uninterrupted ART vital to longevity - new study
Staying on antiretroviral therapy (ART) to keep viral loads low is
better than taking structured breaks from the drugs, a study by the US's
National Institute for Allergy and Infectious Diseases (NIAID) has
revealed.
Treatment interruptions became a topic of much debate amongst HIV
researchers after a handful of people who had previously taken anti-AIDS
treatment maintained very low levels of viral load, even when they
stopped their treatment.
Although antiretroviral medication improves the chances of living
longer, the side effects and costs of the complex life-long regimes and
the threat of drug resistance with long-term use has made doctors and
patients look for alternative ways of using them, especially in
developing countries.
More details:
http://www.plusnews.org/AIDSreport.asp?ReportID=5632
SOUTH AFRICA: Concern as MSF starts handover of HIV/AIDS treatment
After five years of groundbreaking work in the treatment of HIV/AIDS,
medical humanitarian agency Medecins Sans Frontiers (MSF) are preparing
to pull out of their most successful South African programme.
They began offering antiretroviral therapy (ART) in the poverty stricken
Cape Town township of Khayelitsha in 2001, when the provision of
anti-AIDS drugs in the public sector was still illegal. The South
African government deemed the rollout too complex and expensive to
implement.
"Doctors within MSF were frustrated by the positive impact
antiretroviral therapy (ART) was having elsewhere, while thousands
continued to die prematurely in South Africa," explained Dr Eric
Goemaere, head of mission for MSF South Africa.
More details:
http://www.plusnews.org/AIDSreport.asp?ReportID=5631
ZIMBABWE: More children abused as situation worsens
The worsening humanitarian situation in Zimbabwe is making children more
vulnerable to abuse, according to child rights NGOs.
"For instance, because of the hike in school fees many children are
visiting schools [trying to negotiate payment] - it makes them more
vulnerable at the hands of teachers who exploit them," said Witness
Chikoko, acting director of the African Network for the Prevention and
Protection Against Child Abuse and Neglect.
Staff at a boarding primary school near Marondera outside the capital,
Harare, were recently charged with abusing 52 girls, while 14 primary
school girls were also allegedly abused by staff members at a school in
the capital.
More details:
http://www.plusnews.org/AIDSreport.asp?ReportID=5629
NAMIBIA: Poor access to treatment hampers fight against TB
Despite its status as a middle-income country, Namibia has a high
incidence of tuberculosis (TB), a poverty-related disease.
Poor geographical access to health services has hampered the treatment
rate of TB, the country's second biggest killer, said Alfons Babie, an
official at the recently created directorate for special diseases in the
health ministry. Instead of the international target of 85 percent
stipulated by the World Health Organisation (WHO), the TB treatment rate
in Namibia is only 64 percent.
More details:
http://www.plusnews.org/AIDSreport.asp?ReportID=5636
ZAMBIA: Promising new combination therapy reduces MTCT
Zambia's government has begun using a new drug in its prevention of
mother-to-child transmission (PMTCT) programme, in an effort to reduce
drug resistance in both mother and infant.
Dr Miriam Chipimo, reproductive health specialist at the Central Board
of Health (CBoH), told PlusNews that Nevirapine was now being used in
combination with the anti-AIDS drug, Zidovudine, also known as AZT.
Although a single dose of Nevirapine reduces the rate of HIV
transmission, scientists have found that a combination of
antiretrovirals (ARVs) can result in lower rates of Nevirapine
resistance.
More details:
http://www.plusnews.org/AIDSreport.asp?ReportID=5637
SWAZILAND: Campaign to inform women of their legal rights underway
The Swaziland branch of Women in Law in Southern Africa has launched an
awareness campaign to teach HIV-positive women about their legal rights.
"There are three issues: acquainting HIV-positive women with their
protection under existing laws, finding legal representation for women
when they have a case to make and, finally, changing antiquated laws
that need to be reformed to take into consideration gender rights and
AIDS," president of the women's law society, Lomcebo Dlamini, told
PlusNews in an interview.
In a country that only elevated the legal status of women from minors to
adults at the beginning of 2006, where the estimated HIV prevalence is
40 percent and widespread stigma and discrimination are ongoing
problems, few have turned to the legal system for relief.
More details:
http://www.plusnews.org/AIDSreport.asp?ReportID=5641
EVENTS
The Centre for African Family Studies (CAFS) will be holding a training
course on the 'Advances in Behaviour Change Communication for HIV/AIDS'
in Nairobi, Kenya, from 17 July to 4 August 2006. This is an intensive
three-week learning opportunity for programme managers, health
educators, programme officers, and donor agency field staff.
Facilitated by international behaviour change communication experts,
participants in this course are guided to explore and understand the
elements of effective behaviour change communication in HIV/AIDS
programmes, with particular emphasis on how to motivate people to
initiate and sustain behaviour change.
The tuition fee is US $2,800 for the three-week course, which covers
tuition, training materials, supplies, training-related field trips and
certification awards.
For more information visit the CAFS website www.cafs.org or contact The
Director, Centre for African Family Studies, Pamstech House, Woodvale
Grove, Westlands P.O. Box 60054 00200, Nairobi, Kenya. Fax: +254 20
4448621 Email: courses@cafs.org
2. In August 2006, 20,000 researchers, activists, community workers and
people living with HIV/AIDS from around the world will descend upon
Toronto, Canada, for the XVI International AIDS Conference.
In the days leading up to the conference, the AIDS Committee of Toronto
(ACT) and partner organisations from across Canada and other parts of
the world will host an affiliated event on issues affecting gay,
bisexual and other men who have sex with men (MSM) and the organisations
that work with them.
The two-day event, confirmed for 10-11 August, will bring together AIDS
and human rights organisations from developing and industrialised
countries, in the hope of establishing long-term, far-reaching networks
that bridge continents, cultures and issues.
The draft goal and objectives of the event are as follows:
Goal:
To support ongoing connections between individuals and organisations
working with gay, bisexual and other men who have sex with men (MSM) in
the area of HIV/AIDS.
Objectives:
1. Provide opportunities for dialogue on issues related to HIV/AIDS and
gay, bisexual and other MSM
2. Facilitate discussions of HIV prevention for gay, bisexual and other
MSM
3. Highlight emerging issues and responses related to gay men and
HIV/AIDS
4. Discuss ways to advance the leadership of gay, bisexual and other MSM
in the HIV/AIDS pandemic
For more information, and feedback on the goal and objectives of the
event, please contact:
Rick Marchand
Community Based Research Centre Vancouver, Canada
Email: rmarchand@telus.net
rmarchand@telus.net
Deadline for input: 7 February 2006
JOBS
The Global Fund to Fight AIDS, Tuberculosis and Malaria is recruiting
experts to serve on the Technical Review Panel (TRP).
The TRP, which has 26 members, plays a crucial role in reviewing
proposals submitted to the Global Fund and ensuring that those funded
are of high quality.
Individuals with expert technical knowledge and extensive experience in
one of the following are sought:
- HIV/AIDS
- Tuberculosis
- Malaria
- Crosscutting issues (such as institutional and governance issues,
macro-economics in a health sector context)
The current term of appointment is four rounds of proposals. TRP members
must be available for the two-week TRP meetings in Geneva every 12
months. In addition, TRP members need to be accessible by email for up
to six months for the clarification process for the proposals approved
by the Board. Fluency in English is required, as this is the working
language of the TRP.
A transparent criteria-based selection process will be followed, which
seeks to achieve a significant proportion of members from each of the
WHO regions, and representation from public and private sectors and
civil society, including a qualified member from the Persons Living with
AIDS, Tuberculosis and/or Malaria community. A balanced gender
representation is sought.
Applicants from the private sector with extensive experience are
strongly encouraged. The private-sector experience need not be limited
to the pharmaceutical industry: experience in managing private health
systems or healthcare in the developing world would be very useful.
Individuals with expertise in HIV/AIDS and/or crosscutting issues, who
also have specific nutritional expertise, are also encouraged to apply.
Moreover, short-listed candidates will be used as the source for new TRP
members for the next two rounds.
For more details and to download an Application Form, please visit the
Global Fund website: www.theglobalfund.org
Or download the Form from HLSP's website:
www.hlsp.org/workingwithus/globalfund
Completed application forms should be sent to: globalfund.trp@hlsp.org
to arrive no later than Friday 3 March 2006.
Applicants without Internet access should contact the local WHO or
UNAIDS office for assistance.
IRIN-SA
Tel: +27 11 895-1900
Fax: +27 11 784-6759
Email: IRIN-SA@irin.org.za
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Appropriate Donations for International Disaster/Humanitarian Needs
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Center for International web: www.cidi.org
Disaster Information listserv: www.cidi.org/listsub.htm
guidelines: www.cidi.org/donate.htm
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
HIV-AIDS Weekly Issue www.cidi.org/humanitarian/hivaids